Trial · NCT00577993
Adverse events42
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 42
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal Pain | Gastrointestinal disorders | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 21 | 78 | |
| other | Abdominal Pain | Gastrointestinal disorders | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 16 | 80 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 26 | 78 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 35 | 80 | |
| other | Fatigue | General disorders | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 44 | 78 | |
| other | Fatigue | General disorders | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 48 | 80 | |
| other | Fever | General disorders | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 14 | 78 | |
| other | Fever | General disorders | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 20 | 80 | |
| other | Neutropenic Fever | Blood and lymphatic system disorders | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 14 | 78 | |
| other | Neutropenic Fever | Blood and lymphatic system disorders | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 9 | 80 | |
| other | Infection | Infections and infestations | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 17 | 78 | |
| other | Infection | Infections and infestations | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 18 | 80 | |
| other | Nausea / Emisis | Gastrointestinal disorders | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 7 | 78 | |
| other | Nausea / Emisis | Gastrointestinal disorders | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 13 | 80 | |
| other | Neuropathy | Nervous system disorders | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 21 | 78 | |
| other | Neuropathy | Nervous system disorders | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 14 | 80 | |
| other | Rash / Pruitius | Skin and subcutaneous tissue disorders | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 10 | 78 | |
| other | Rash / Pruitius | Skin and subcutaneous tissue disorders | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 18 | 80 | |
| other | Neutropenia | Blood and lymphatic system disorders | Fludarabine,Mitoxantrone, and Dexamethasone (FND)-Rituximab | 67 | 78 | |
| other | Neutropenia | Blood and lymphatic system disorders | Rituximab- Fludarabine,Mitoxantrone, and Dexamethasone (FND) | 13 | 80 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00577993/events